Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis
- PMID: 233166
- DOI: 10.1093/clinids/1.3.401
Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis
Abstract
The nature of the pathogenesis and of the prolonged immunity of whooping cough has not been clearly defined. The literature of Bordetella pertussis indicated that only the antigen that induces histamine sensitization, lymphocytosis, and other biological reactions in mice is the cause of the harmful effects and prolonged immunity of whooping cough. This antigen has the general characteristics of bacterial protein exotoxins that cause the harmful effects of infectious diseases such as diphtheria and tetanus. It is proposed that this antigen, which is histamine-sensitizing, lymphocyte-leukocyte-promoting, and islets-activating (HSF-LPF-IAP), be designated pertussis toxin. Agglutinogen, hemagglutinin, and heat-labile (at 56 C) and heat-stable (at 100 C) toxins are no doubt interrelated with the immunologic and/or toxic reactions of whooping cough. It appears that the first defense against the disease is the antibody that prevents adhesion of the bacteria to the cilia of the respiratory epithelium and that the second defense is the antitoxin against pertussis toxin (HSF-LPF-IAP).
Similar articles
-
The concept of pertussis as a toxin-mediated disease.Pediatr Infect Dis. 1984 Sep-Oct;3(5):467-86. doi: 10.1097/00006454-198409000-00019. Pediatr Infect Dis. 1984. PMID: 6093069 Review.
-
Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.Microbiol Immunol. 1984;28(5):509-15. doi: 10.1111/j.1348-0421.1984.tb00703.x. Microbiol Immunol. 1984. PMID: 6088952
-
Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.Infect Immun. 1983 May;40(2):523-8. doi: 10.1128/iai.40.2.523-528.1983. Infect Immun. 1983. PMID: 6301999 Free PMC article.
-
[Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].Med Dosw Mikrobiol. 2013;65(4):269-74. Med Dosw Mikrobiol. 2013. PMID: 24730215 Polish.
-
Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.Pediatrics. 2001 Dec;108(6):E115. doi: 10.1542/peds.108.6.e115. Pediatrics. 2001. PMID: 11731642 Review.
Cited by
-
Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit.Proc Natl Acad Sci U S A. 1989 Nov;86(21):8353-7. doi: 10.1073/pnas.86.21.8353. Proc Natl Acad Sci U S A. 1989. PMID: 2554311 Free PMC article.
-
The primary and secondary cellular immune responses to whole cell Bordetella pertussis vaccine and its components.Clin Exp Immunol. 1987 May;68(2):275-81. Clin Exp Immunol. 1987. PMID: 3498569 Free PMC article.
-
Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin.Infect Immun. 1992 Sep;60(9):3528-32. doi: 10.1128/iai.60.9.3528-3532.1992. Infect Immun. 1992. PMID: 1500160 Free PMC article.
-
Immune response to the B oligomer of pertussis toxin.Infect Immun. 1987 May;55(5):1132-6. doi: 10.1128/iai.55.5.1132-1136.1987. Infect Immun. 1987. PMID: 3570457 Free PMC article.
-
Mutations in the S1 subunit of pertussis toxin that affect secretion.Infect Immun. 2000 Mar;68(3):1276-81. doi: 10.1128/IAI.68.3.1276-1281.2000. Infect Immun. 2000. PMID: 10678938 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials